Erbitux (cetuximab) is a prescription drug that’s used to treat certain types of cancer. The drug comes as a solution that’s given through a vein by a healthcare professional. It’s usually ...

We recently published a list of Bitcoin Miners, Quantum Computing Lead Rally: A Look at Wednesday’s Top 10 Gainers.

FDA approved Braftovi, Erbitux, and mFOLFOX6 for BRAF V600E mutation-positive metastatic colorectal cancer. BREAKWATER trial showed a 61% objective response rate for the treatment group versus 40% for ...

Needham upgraded its price target for Bitdeer by 57 percent to $22 from $14, while giving it a “buy” rating, indicating an ...

The NRG-HN004 trial showed that durvalumab did not improve outcomes vs cetuximab in locoregionally advanced head and neck ...

Pharmac has made significant strides in reducing the time required for decision-making processes, particularly for the Named ...

This study identifies key market drivers and trends, aiming to forecast the growth trajectory for each industry in Saudi Arabia over the next few years. The report presents a detailed picture of the ...

On December 20, 2024, the FDA granted accelerated approval to the combination of encorafenib (Braftovi), cetuximab (Erbitux), ...

”Increasing availability of medicines has always been a priority of mine. Access to pharmaceuticals for many is life or death ...

Associate Health Minister David Seymour says he is proud of the Government's commitment to increasing medicines access for New Zealanders, resulting ...

The agency approved the medication, also known as encorafenib, to be used in combination with cetuximab, also known as Erbitux, and mFOLFOX6 chemotherapy for the treatment of patients with mCRC ...